Vulvovaginal Atrophy

Vulvovaginal Atrophy

Vulvovaginal atrophy (VVA) is a condition which occurs when the tissues of the vulva and vagina become thinner, drier and less elastic.

Vulvovaginal atrophy is a common condition that affects many women during menopause due to the decreased levels of estrogen in the body. It is especially common among women who have had their ovaries removed (surgical menopause) or those who are undergoing hormone replacement therapy (HRT).

Some of the common symptoms associated with vulvovaginal atrophy include:

  • Vaginal dryness or burning sensation
  • Vaginal itching
  • Painful intercourse
  • Light bleeding during intercourse
  • Vaginal discharge
  • Increased urinary tract or bladder infections

Vulvovaginal atrophy can be treated with topical estrogen therapy. This can take the form of creams, tablets, rings, or vaginal inserts. It is important to note that topical estrogen should not be used with women who are pregnant, breastfeeding, or with those who are at risk for breast cancer.

Other lifestyle changes such as avoiding irritants and vulvar products, using lubricants during sexual intercourse, and wearing cotton underwear can help to prevent VVA from worsening. It is also important to consult a healthcare professional if you are experiencing any symptoms associated with VVA.